98%
921
2 minutes
20
Background/objectives: Controlling colonoscopic quality is important in the detection of colon polyps during colonoscopy as it reduces the overall long-term colorectal cancer risk. Artificial intelligence has recently been introduced in various medical fields. In this study, we aimed to validate a previously developed artificial intelligence (AI) computer-aided detection (CADe) algorithm called ALPHAON and compare outcomes with previous studies that showed that AI outperformed and assisted endoscopists of diverse levels of expertise in detecting colon polyps.
Methods: We used the retrospective data of 500 still images, including 100 polyp images and 400 healthy colon images. In addition, we validated the CADe algorithm and compared its diagnostic performance with that of two expert endoscopists and six trainees from Gachon University Gil Medical Center. After a washing-out period of over 2 weeks, endoscopists performed polyp detection on the same dataset with the assistance of ALPHAON.
Results: The CADe algorithm presented a high capability in detecting colon polyps, with an accuracy of 0.97 (95% CI: 0.96 to 0.99), sensitivity of 0.91 (95% CI: 0.85 to 0.97), specificity of 0.99 (95% CI: 0.97 to 0.99), and AUC of 0.967. When evaluating and comparing the polyp detection ability of ALPHAON with that of endoscopists with different levels of expertise (regarding years of endoscopic experience), it was found that ALPHAON outperformed the experts in accuracy (0.97, 95% CI: 0.96 to 0.99), sensitivity (0.91, 95% CI: 0.85 to 0.97), and specificity (0.99, 95% CI: 0.97 to 0.99). After a washing-out period of over 2 weeks, the overall capability significantly improved for both experts and trainees with the assistance of ALPHAON.
Conclusions: The high performance of the CADe algorithm system in colon polyp detection during colonoscopy was verified. The sensitivity of ALPHAON led to it outperforming the experts, and it demonstrated the ability to enhance the polyp detection ability of both experts and trainees, which suggests a significant possibility of ALPHAON being able to provide endoscopic assistance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11640539 | PMC |
http://dx.doi.org/10.3390/diagnostics14232762 | DOI Listing |
medRxiv
August 2025
Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA 02115, USA.
Background: Obstructive sleep apnea (OSA) is associated with a wide range of comorbidities, but large-scale phenome-wide analyses in clinical biobanks remain under-reported. In this study, we identified common comorbidities enriched in patients with OSA, tested the temporality of these associations, and analyzed relevant associations with summary sleep recording data.
Methods: 48,251 participants with OSA in the Mass General Brigham healthcare system were identified using a natural language processing phenotyping algorithm and/or evidence of an elevated apnea-hypopnea index (AHI).
J Clin Lipidol
September 2025
Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, TX, USA. Electronic address:
Background: Familial hypercholesterolemia (FH) is an inherited cholesterol disorder that is markedly underdiagnosed.
Objective: This study evaluated the real-world performance of the Find, Identify, Network, Deliver-FH (FIND-FH) score, a novel machine learning algorithm, in identifying individuals with high likelihood of FH.
Methods: The FIND-FH model was applied to electronic health record (EHR) data from UT Southwestern Medical Center.
Nat Med
July 2025
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Polygenic scores (PGSs) for body mass index (BMI) may guide early prevention and targeted treatment of obesity. Using genetic data from up to 5.1 million people (4.
View Article and Find Full Text PDFiScience
July 2025
Department of General Surgery, Peking University Third Hospital, Beijing, China.
Artificial intelligence (AI) is increasingly integrated into the clinical management of colorectal cancer (CRC), playing a role in areas ranging from disease screening and therapy assistance to daily care and prognostic assessment. While AI's capabilities are clear, several challenges, including those related to ethics, data privacy, and deployment, must be addressed to fully realize its potential in driving innovation and advancing medical technologies. In this review, we provide a comprehensive summary of AI's applications in the clinical management of CRC, examine the areas in which it has been incorporated, and discuss the limitations and key considerations that will guide future research.
View Article and Find Full Text PDFBest Pract Res Clin Gastroenterol
June 2025
Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Quality of care during endoscopy is greatly influenced by endoscopists' competence and efforts, which is unfortunately subject to variability. The recent transformative role of artificial intelligence (AI) is expected to improve endoscopy quality in a objective way, potentially eliminating inter-endoscopist variability in endoscopy performance. AI aids in real-time detection (CADe) and characterization (CADx) of colorectal polyps, quality assurance of colonoscopy (CAQ), and workflow optimization including surveillance interval support and endoscopy reporting.
View Article and Find Full Text PDF